DIRAGO PROBIOTICS FEATURES TWO OF THE MOST HUMAN CLINICALLY RESEARCHED PROBIOTIC STRAINS (LACTOBACILLUS RHAMNOSUS GG & BIDIDOBACTERIUM LONGUM BB536)
Lactobacilli probiotics exert their health effects mostly in the gastrointestinal tract, where they influence the intestinal microbiota.
The probiotic strain with the highest level of substantiating evidence is Lactobacillus rhamnosus GG. In addition, several randomized clinical trials showed that Lactobacillus rhamnosus GG is most effective in treating infectious and antibiotic associated diarrhea at a daily dose of 10 billion CFU.
Bifidobacteria are considered "friendly" bacteria and are used for the purpose of recolonising the intestinal microbiota. The human body relies on a healthy intestinal flora for metabolizing foods and absorbing nutrients.
Digesting Bifidobacterium longum BB536 daily can increase the number of bowel movements. This health benefit has been confirmed by several clinical trials.
Lactobacilli and Bifidobacteria seem to modulate immune functions by stimulating the activities of the white blood cells (macrophages). The added vitamin D enhances the immune system’s response to both bacterial and viral agent primarily through promoting activities of the white blood cells (macrophages).